TFF Pharmaceuticals Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed
Portfolio Pulse from Benzinga Newsdesk
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) has announced its intention to offer and sell shares of its common stock in an underwritten public offering. The size and amount of the offering have not been disclosed. The company also plans to grant the underwriters a 30-day option to purchase additional shares. The offering is subject to market conditions and the company intends to use the net proceeds for working capital and general corporate purposes. The Benchmark Company, LLC is acting as sole book-running manager for the offering.
August 14, 2023 | 8:44 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TFF Pharmaceuticals' announcement of a public offering of common stock could potentially dilute existing shareholders' equity, which may lead to a short-term decrease in stock price.
Public offerings often lead to dilution of existing shareholders' equity, which can result in a decrease in stock price. However, the proceeds from the offering will be used for working capital and general corporate purposes, which could potentially strengthen the company's financial position in the long term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100